This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
The Optic Neuritis Treatment Trial.—Recruitment is continuing for the Optic Neuritis Treatment Trial, a prospective, randomized, collaborative, clinical trial sponsored by the National Eye Institute, National Institutes of Health. The primary objective of this study is to determine the value of oral prednisone and intravenous methylprednisolone in the treatment of optic neuritis. In 1 year, 190 patients were entered into the treatment trial at the 15 participating centers. This exceeded the expected number by 30%, but additional patients are still needed. For information regarding patient referrals, contact Roy W. Beck, MD, ONTT Chairman, USF Eye Institute, 13131 Magnolia Dr, Tampa, FL 33612; (813) 977-8129.
—The International Conference on Low Vision 1990 was held in Melbourne, Australia, in March 1990 with 275 delegates attending from 27 countries. The audio taped proceedings from this conference are now available. For ordering information, contact Margaret Lawrence, Conference Organizer, Association for the